Nanobodies that target LRRK2 could have potential for Parkinson's Date 7 March 2022 Treatments targeting a protein called LRRK2 are currently being tested in clinical trials for Parkinson's. Researchers hope they may have the ability to slow the progression of the condition which is something no current treatment can do.
Caption Man with Parkinson's talking to a health professional New early signs of Parkinson's uncovered in most diverse UK study to date Date 7 March 2022 Researchers at Queen Mary University of London have reported results from the first UK study of the early signs of Parkinson's in a highly diverse population.
Vitamin B3 supplement shows early promise for Parkinson's Date 7 March 2022 Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
Caption A person holding a handful of berries Positive effect of a flavonoid-rich diet seen in people with Parkinson's Date 15 February 2022 Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.
Exercise improves symptoms by changing the way the brain works Date 18 January 2022 Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.
Working together to drive forward race equality in research Date 21 December 2021 We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.
Take part in groundbreaking research to test drugs to combat coronavirus Date 14 December 2021 If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Caption Research pipette Parkinson's protein test could lead to earlier and better diagnosis Date 13 December 2021 Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
We're investing up to £3m in drugs that could slow the progression of Parkinson’s Date 6 December 2021 We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.
Clinical trial of new dyskinesia drug starts in Sweden Date 30 November 2021 The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.
